{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:02:56Z","timestamp":1791896576011,"version":"4.3.4"},"reference-count":30,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T00:00:00Z","timestamp":1205712000000},"content-version":"vor","delay-in-days":5189,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1994,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>OBJECTIVE <\/jats:bold> The release of growth hormone (GH) from the anterior pituitary is partly under cholinergic control. Pyridostigmine, the acetylcholinesterase inhibitor, releases GH by this mechanism. Pyridostigmine\/GH responses have been reported as enhanced in depression. The aim of the current study was to examine such responses during a manic episode.<\/jats:p><jats:p><jats:bold>DESIGN <\/jats:bold> A between subjects design was employed.<\/jats:p><jats:p><jats:bold>SUBJECTS <\/jats:bold> Seven male manic patients and seven male healthy controls were studied. They were matched in terms of age and body mass index.<\/jats:p><jats:p><jats:bold>MEASUREMENTS <\/jats:bold> GH response to pyridostigmine (120 mg) challenge was measured as the net increase above baseline. Cortisol levels were also measured.<\/jats:p><jats:p><jats:bold>RESULTS <\/jats:bold> Release of GH in the manic patients was significantly enhanced and their baseline Cortisol levels were elevated.<\/jats:p><jats:p><jats:bold>CONCLUSIONS <\/jats:bold> These results demonstrate enhanced pyridostigmine\/GH responsiveness in mania which may be due to enhanced somatostin tone or increased cholinergic receptor responsivity.<\/jats:p>","DOI":"10.1111\/j.1365-2265.1994.tb02449.x","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T11:02:12Z","timestamp":1205751732000},"page":"93-96","source":"Crossref","is-referenced-by-count":13,"title":["Pyridostigmine induced growth hormone release in mania: focus on the cholinergic\/somatostatin system"],"prefix":"10.1111","volume":"40","author":[{"given":"Timothy G.","family":"Dinan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"O'Keane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jogin","family":"Thakore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,3,17]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(87)90034-5"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/acps.1980.61.s280.183"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(85)90021-7"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(86)90246-5"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.148.7.936"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(61)92004-9"},{"key":"e_1_2_1_8_1","first-page":"40","article-title":"Sleep disturbance in depression: diagnostic potential and pathophysiology","volume":"16","author":"Gillin J.C","year":"1980","journal-title":"Psychopharmacology Bulletin"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1530\/acta.0.1220206"},{"key":"e_1_2_1_10_1","first-page":"257","article-title":"The administration of diisopropylfluorophosphonate (DFP) to man","volume":"81","author":"Grob D.","year":"1947","journal-title":"Johns Hopkins Hospital Bulletin"},{"key":"e_1_2_1_11_1","first-page":"186","article-title":"Erythrocyte and plasma choline in bipolar psychiatric patients: a follow\u2010up study","volume":"18","author":"Hanin I.","year":"1982","journal-title":"Psycho-pharmacology Bulletin"},{"key":"e_1_2_1_12_1","first-page":"261","article-title":"Physostigmine induction of REM sleep in imipramine treated rats","volume":"3","author":"Hill S.Y.","year":"1979","journal-title":"Communications in Psychopharmacology"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(72)93021-8"},{"key":"e_1_2_1_14_1","first-page":"353","article-title":"Mood elevating effects of trihexyphenidyl and biperidin in individuals taking antipsychotic medication","volume":"38","author":"Jellinek T.","year":"1979","journal-title":"Diseases of the Nervous System"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.142.3.356"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1019597"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1159\/000123857"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199100620-00005"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.139.5.565"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.75.1.11"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700032724"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1973.tb04418.x"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.289.6445.612"},{"key":"e_1_2_1_24_1","volume-title":"Evaluation of Growth Hormone Secretion","author":"Raite S.","year":"1983"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo-107-1-122"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(81)90012-3"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1987.tb02957.x"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.122.5.509"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.7361118"},{"key":"e_1_2_1_30_1","volume-title":"Statgraphics","author":"Statistical Graphics Corporation","year":"1987"},{"key":"e_1_2_1_31_1","first-page":"486","article-title":"Long\u2010term therapy with anticholinergic drugs in psychiatric patients","volume":"29","author":"Tislow R.F.","year":"1970","journal-title":"Pharmacology"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.1994.tb02449.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.1994.tb02449.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T08:21:02Z","timestamp":1698222062000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.1994.tb02449.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1994,1]]}},"alternative-id":["10.1111\/j.1365-2265.1994.tb02449.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.1994.tb02449.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,1]]}}}